48 resultados para brown stock screening
Resumo:
This inaugural annual report for the Northern Ireland Abdominal Aortic Aneurysm (AAA) Screening Programme (produced jointly by the Public Health Agency and the Belfast Health and Social Care Trust) looks back on a successful first year for the programme. The Public Health Agency (PHA) is responsible for commissioning and quality assuring the programme. The Belfast Health and Social Care Trust is responsible for providing and managing the programme.Following significant planning, AAA screening was introduced on time in June 2012, as required by the Government's 'Priorities for Action' target. There is no doubt that this was due to sustained partnership working across a wide range of health and social care services within Northern Ireland.
Resumo:
From January 2011, the Northern Ireland cervical screening programme no longer invited women aged under 25 to attend for screening. In addition, the screening interval for women aged 25-49 was reduced to every three years.This�booklet describes the rationale for the change in policy so that primary care staff and smear takers can provide appropriate and accurate advice to patients.
Resumo:
As you have diabetes, your GP has arranged foryou to attend the Diabetic Retinopathy Screening Programme. This service is free and is provided aspart of your diabetes care.
Resumo:
This leaflet is used to support the Northern Ireland breast screening programme and explains the additional tests that may be offered at a breast assessment clinic following a mammogram that has shown a possible abnormality�
Resumo:
This leaflet is used to support the Northern Ireland breast screening programme and help women decide whether to attend breast screening. Translations are of the 2014 version.This is also available in audio format by clicking�here.�
Resumo:
Your baby will be given a series of routine health checks in the first few weeks of life. This will include a hearing screen. The hearing screen uses a quick simple test to check the hearing of all newborn babies. � .
Resumo:
The newborn blood spot pre-screening information leaflet for parents has been revised to include information about sickle cell disorders (SCD) and medium chain�acyl coA dehydrogenase deficiency (MCADD) family history. The revised pre-screening leaflet should be given to all pregnant women by 30 weeks gestation and reissued to parents following delivery, before day five.Further information about screening and the care of children with SCD is available at:
Resumo:
This booklet is aimed at GPs and practice managers to enable them to promote informed choice for women invited for breast screening.
Resumo:
This information leaflet is for all men invited to take part in the Northern Ireland Abdominal Aortic Aneurysm (AAA) Screening Programme. Men will automatically be invited for screening in their 65th year, while men aged over 65 can request a scan through the central screening office.
Resumo:
This leaflet explains breast screening for women with a higher risk of breast cancer.
Resumo:
Information for patients being screened for Carbapenemase Producing Enterobacteriaceae/Carbapenemase Producing Organism (CPE/CPO)
Resumo:
This leaflet provides step-by-step instructions on using the Faecal Immunochemical�Test (FIT) for bowel cancer screening. This kit is slightly different to the one we usually use as part of Northern Ireland��'s bowel cancer screening programme. It is easier to complete for people who are partially sighted and is sent following discussion with the screening helpline team.
Resumo:
This leaflet provides information on bowel cancer and the Northern Ireland Bowel cancer screening programme.The translations are of the 2010 versions when screening was for 60-69 year olds but this has been extended to 60-74 year olds.
Resumo:
This leaflet provides step by step instructions on using the Faecal Occult Blood test (FOBt) for bowel cancer screening.The translations are of the 2010 versions when screening was for 60��-69 year olds but this has been extended to 60��-74 year olds.
Resumo:
This leaflet provides information on further investigations participants may require, including colonoscopy.The translations are of the 2010 versions when screening was for 60��-69 year olds but this has been extended to 60��-74 year olds.